SCHEMBL5712296

SCHEMBL5712296

CC(C)(C)CC(C)(C)c1ccc2cc(O)ccc2c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SHBG P04278 1/20 0.66
CYP3A4 P08684 5/20 0.46
HIF1A Q16665 2/20 0.46
CYP2D6 P10635 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
ESR1 P03372 4/20 0.42
AR P10275 2/20 0.42
SLC6A2 P23975 2/20 0.42
SLC6A4 P31645 2/20 0.42
SLC6A3 Q01959 2/20 0.42
MEN1 O00255 1/20 0.42
USP2 O75604 1/20 0.42
TP53 P04637 1/20 0.42
PGR P06401 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
MAPT P10636 1/20 0.42
DRD1 P21728 1/20 0.42
PTGS1 P23219 1/20 0.42
PDE4A P27815 1/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30125172 1.00 SHBG (0.66) SHBGCYP3A4HIF1ACYP2D6SMN1; SMN2
SCHEMBL27245484 0.93 SHBG (0.58) SHBGCYP3A4HIF1ACYP2D6SMN1; SMN2
SCHEMBL10040417 0.83 ESR1 (0.45) SHBGCYP3A4HIF1ASMN1; SMN2ESR1
SCHEMBL31015724 0.83 ESR1 (0.45) SHBGCYP3A4HIF1ASMN1; SMN2ESR1
SCHEMBL15124425 0.81 SHBG (0.48) SHBGCYP3A4HIF1ACYP2D6SMN1; SMN2
SCHEMBL20408454 0.80 ESR1 (0.42) SHBGCYP3A4HIF1ASMN1; SMN2ESR1
SCHEMBL10141 0.80 SHBG (1.00) SHBGCYP3A4HIF1ACYP2D6SMN1; SMN2
SCHEMBL31282065 0.80 SHBG (1.00) SHBGCYP3A4HIF1ACYP2D6SMN1; SMN2
SCHEMBL2048078 0.78 LMNA (0.58) CYP3A4HIF1ACYP2D6ESR1AR
SCHEMBL10785821 0.78 SHBG (0.95) SHBGCYP3A4HIF1ACYP2D6SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12384920-B2 Azo iron complex dye, ink composition containing same, and method for producing azo iron complex dye ORIENT CHEMICAL INDUSTRIES CO., LTD. (JP) 2025-08-12 US disclosed
US-20240409746-A1 AZO IRON COMPLEX DYE, INK COMPOSITION CONTAINING SAME, AND METHOD FOR PRODUCING AZO IRON COMPLEX DYE ORIENT CHEMICAL INDUSTRIES CO., LTD. (JP) 2024-12-12 US disclosed
EP-4286367-A1 AZO IRON COMPLEX DYE, INK COMPOSITION CONTAINING SAME, AND METHOD FOR PRODUCING AZO IRON COMPLEX DYE Orient Chemical Industries Co., Ltd. (JP) 2023-12-06 EP disclosed
CN-116783158-A Azo iron complex dye, ink composition containing same, and method for producing azo iron complex dye 东方化学工业株式会社 2023-09-19 CN disclosed
WO-2022163736-A1 AZO IRON COMPLEX DYE, INK COMPOSITION CONTAINING SAME, AND METHOD FOR PRODUCING AZO IRON COMPLEX DYE オリヱント化学工業株式会社 2022-08-04 WO disclosed
EP-1096325-B1 Toner CANON KK (JP) 2006-11-29 EP disclosed
US-6426169-B1 TONER COMPRISING TONER PARTICLES EACH COMPRISING BINDER RESIN, COLORANT AND ORGANOMETALLIC COMPOUND FORMED FROM MONOAZO COMPOUND HAVING AT LEAST ONE ALKYL GROUP AND TWO HYDROXYL GROUPS CAPABLE OF BONDING WITH IRON ATOM CANON KABUSHIKI KAISHA (JP) 2002-07-30 US disclosed
US-20020055053-A1 Toner CANON KABUSHIKI KAISHA (JP) 2002-05-09 US disclosed
EP-1186962-A2 Toner CANON KABUSHIKI KAISHA (JP) 2002-03-13 EP disclosed
EP-1096325-A2 Toner CANON KABUSHIKI KAISHA (JP) 2001-05-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12384920-B2 Azo iron complex dye, ink composition containing same, and method for producing azo iron complex dye IK, SLC40A1, ABCB7 SHBG 2750/4885CYP3A4 290/4885HIF1A 1033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.